UBS analyst Nik Cremo lowered the firm’s price target on Corpay (CPAY) to $315 from $340 and keeps a Neutral rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target lowered to $342 from $380 at BofA
- Corpay Inc’s Strong Performance and Optimistic Future Outlook Justify Buy Rating Despite Market Challenges
- Corpay Inc: Strong B2B Growth Potential and Competitive Edge Justify Buy Rating
- Corpay, Inc. Reports Strong Q3 2025 Financial Results
- Corpay Inc Completes Acquisition of Alpha Group